Skip to main content
OpenTrials
Completed

NCT Number: NCT01221480

What Influences Patient Outcome in Obstructive Airway Disease?

The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Data collected through TARDIS database

Exclusion criteria

  • History of asthma or malignancy. Less than 50 years of age

Treatment and study plan

Primary outcomes

  1. All-cause Mortality

    Time frame: 3000 days

    All-cause Mortality

Secondary outcomes

  1. Hospital Admissions

    Time frame: 3000 days

    Hospital Admissions

  2. COPD exacerbations

    Time frame: 3000 days

    COPD exacerbations

Sponsors and collaborators

Lead sponsor

University of Dundee

Other

Registry information

Official study title

Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Oct 15, 2010
Registry last updated
Apr 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.